ctrl K

Price Alert

Moleculin Biotech Inc. (MBRX)

NASDAQ: MBRX · Real-Time Price · USD

0.60

-0.01 (-1.17%)

At close: Aug 19, 2025, 3:59 PM

0.60

0.69%

After-hours: Aug 19, 2025, 07:03 PM EDT

Moleculin Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4.28M	23.55M	43.15M	70.9M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	159K	n/a	n/a	n/a
Receivables	20K	99K	22K	45K
Inventory	n/a	n/a	-22K	-45K
Other Current Assets	331K	545K	823K	531K
Total Current Assets	5.19M	26.27M	45.6M	72.5M
Property-Plant & Equipment	424K	796K	678K	445K
Goodwill & Intangibles	11.15M	11.15M	11.15M	11.15M
Total Long-Term Assets	11.73M	11.94M	11.83M	11.59M
Total Assets	16.93M	38.22M	57.42M	84.09M
Account Payables	2.03M	2.5M	2.1M	1.36M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	120K	100K	116K	96K
Other Current Liabilities	1.27M	-100K	-116K	1.46M
Total Current Liabilities	5.36M	6.82M	4.82M	3.62M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	5.23M	4.86M	77K	1.41M
Total Long-Term Liabilities	5.59M	5.33M	412K	1.48M
Total Liabilities	10.95M	12.14M	5.23M	5.1M
Total Debt	478K	574K	451K	159K
Common Stock	3K	33K	29K	29K
Retained Earnings	-153.37M	-131.6M	-101.83M	-72.81M
Comprehensive Income	-41K	-9K	12K	41K
Shareholders Equity	5.98M	26.07M	52.19M	78.99M
Total Investments	n/a	n/a	n/a	n/a